Arcadia Biosciences Inc Q4 2023 Earnings Call Transcript - Thomson StreetEvents

Arcadia Biosciences Inc Q4 2023 Earnings Call Transcript

Arcadia Biosciences Inc Q4 2023 Earnings Call Transcript - Thomson StreetEvents
Arcadia Biosciences Inc Q4 2023 Earnings Call Transcript
Published Mar 28, 2024
9 pages (4567 words) — Published Mar 28, 2024
Price US$ 54.00  |  Buy this Report Now

About This Report

  
Abstract:

Edited Transcript of RKDA.OQ earnings conference call or presentation 28-Mar-24 8:30pm GMT

  
Brief Excerpt:

...Operator Good afternoon and welcome to the Arcadia Biosciences fourth quarter and full year 2023 financial results and business highlights conference call. (Operator Instructions) Please be advised that today's conference call is being recorded. I would now like to hand the conference over to TJ Schaefer, Chief Financial Officer at Arcadia, please go ahead. Thomas Schaefer ...

  
Report Type:

Transcript

Source:
Company:
Arcadia Biosciences Inc
Ticker
RKDA.OQ
Time
8:30pm GMT
Format:
PDF Adobe Acrobat
Buy Now

The following is excerpted from the question-and-answer section of the transcript.

(Questions from industry analysts are provided in full, but answers are omitted - download the transcript to see the full question-and-answer session)

Question: Ben Klieve - Lake Street Capital Markets LLC - Analyst : All right. Thanks for taking my questions. First, on the fourth quarter and full-year gross profit and gross margin side-- without the income statement on the press release, I'm having a hard time putting this together. Can you just lay out what the gross profit and gross margin was in both Q4 and on a full-year basis, please?


Question: Ben Klieve - Lake Street Capital Markets LLC - Analyst : Okay, great. And then, okay, I can back that out. So, you know, from when you talk about the outlook for '24, double-digit revenue growth, but TJ, you commented that given some of the portfolio shifts, I expect margins to come down a bit. Can you talk about your expectations for gross profit improvement from 2023 to 2024?


Question: Ben Klieve - Lake Street Capital Markets LLC - Analyst : Got it. Okay. That's helpful. Thank you. So, turning to the comments you made on trying to recognize some royalty revenue and partnering with the wheat supply chain and working with the larger food manufacturers. Especially working with the supply chain was something that had been tried, a couple of years ago. And, you know, not just at Arcadia, but industry-wide, it's been a real challenge for these kind of novel, enhanced nutrition varieties to really find their way into the supply chain with these big players. Can you talk about the conversations that you're having today and give us a sense that these-- large, -- wheat companies are really serious about engaging with, technology like you've developed?


Question: Ben Klieve - Lake Street Capital Markets LLC - Analyst : Okay. Great. Very good. On GoodWheat, a question on GoodWheat, a question on Zola, and then I'll get back in queue here. In GoodWheat, you know, you're six months now into the launch of Pancake Mix. I'm wondering if you can talk about kind of the performance of these new products today versus kind of the performance of pasta six months in after you launched them. Are you, realizing revenue synergies now that you've got more products in line or is kind of the ramp over the first six months kind of similar today as it was when you started GoodWheat a couple of years ago now?


Question: Ben Klieve - Lake Street Capital Markets LLC - Analyst : Can you really tell on anything on Mac and Cheese. REFINITIV STREETEVENTS | www.refinitiv.com | Contact Us consent of Refinitiv. 'Refinitiv' and the Refinitiv logo are registered trademarks of Refinitiv and its affiliated companies. MARCH 28, 2024 / 8:30PM, RKDA.OQ - Q4 2023 Arcadia Biosciences Inc Earnings Call


Question: Ben Klieve - Lake Street Capital Markets LLC - Analyst : Okay. Very good. Thank you. And then one last one for me, and Zola, you talk about expanding distribution, new SKUs coming online here. You also, in your latest investor presentation layout, target of expanding this from a 4% ACV in 2022 to 40% in 2025. Can you comment on kind of what that number was exiting '23 and then collectively how all these dynamics will improve that number. How much that number will be improved in 24?


Question: Ben Klieve - Lake Street Capital Markets LLC - Analyst : Got it. Very good. Okay. I appreciate you taking my questions. I'll get back in queue.


Question: Dipesh Patel - H.C. Wainwright & Co - Analyst : Hi, Stan. Hi, TJ. This is Dipesh on behalf of Ram Selvaraju at HC Wainwright. I've got a couple of questions with regards to revenue, and then just one or other on the strategic review process. So the first one, what do you consider the most valuable and fastest-growing product line from the GoodWheat franchise? Would you say it's Mac and Cheese, Qukcakes, or pasta?


Question: Dipesh Patel - H.C. Wainwright & Co - Analyst : Got it. And then I guess a follow-up question on the GoodWheat distribution channel. Which one would you say appears to be most profitable at this point?


Question: Dipesh Patel - H.C. Wainwright & Co - Analyst : Okay. And then just a couple more. What innovative strategies can the company use to boost revenue growth in the coming quarters?


Question: Dipesh Patel - H.C. Wainwright & Co - Analyst : Great. That's helpful. And then last question from me, when does the company plan to complete the strategic review process?


Question: Dipesh Patel - H.C. Wainwright & Co - Analyst : Got it. Thank you for taking my questions.

Table Of Contents

Arcadia Biosciences Inc Q4 2024 Earnings Call Transcript – 2025-03-20 – US$ 54.00 – Edited Transcript of RKDA.OQ earnings conference call or presentation 20-Mar-25 8:30pm GMT

Arcadia Biosciences Inc To Discuss Key Details And Benefits of The Transaction -M&A Call Transcript – 2024-12-11 – US$ 54.00 – Edited Transcript of RKDA.OQ M&A conference call or presentation 11-Dec-24 9:30pm GMT

Arcadia Biosciences Inc Q3 2024 Earnings Call Transcript – 2024-11-12 – US$ 54.00 – Edited Transcript of RKDA.OQ earnings conference call or presentation 12-Nov-24 9:30pm GMT

Arcadia Biosciences Inc Q2 2024 Earnings Call Transcript – 2024-08-13 – US$ 54.00 – Edited Transcript of RKDA.OQ earnings conference call or presentation 13-Aug-24 8:30pm GMT

Arcadia Biosciences Inc Annual Shareholders Meeting Transcript – 2024-06-25 – US$ 54.00 – Edited Transcript of RKDA.OQ shareholder or annual meeting 25-Jun-24 6:00pm GMT

Arcadia Biosciences Inc Q3 2023 Earnings Call Transcript – 2023-11-09 – US$ 54.00 – Edited Transcript of RKDA.OQ earnings conference call or presentation 9-Nov-23 9:30pm GMT

Arcadia Biosciences Inc Q2 2023 Earnings Call Transcript – 2023-08-10 – US$ 54.00 – Edited Transcript of RKDA.OQ earnings conference call or presentation 10-Aug-23 8:30pm GMT

Arcadia Biosciences Inc Q1 2023 Earnings Call Transcript – 2023-05-11 – US$ 54.00 – Edited Transcript of RKDA.OQ earnings conference call or presentation 11-May-23 8:30pm GMT

Arcadia Biosciences Inc Q4 2022 Earnings Call Transcript – 2023-03-30 – US$ 54.00 – Edited Transcript of RKDA.OQ earnings conference call or presentation 30-Mar-23 8:30pm GMT

Arcadia Biosciences Inc Q3 2022 Earnings Call Transcript – 2022-11-10 – US$ 54.00 – Edited Transcript of RKDA.OQ earnings conference call or presentation 10-Nov-22 9:30pm GMT

More from Thomson StreetEvents

Thomson StreetEvents—Thomson StreetEvents is a leading provider of Web-based solutions for the investment community, offering services that transform the way companies communicate and meet disclosure requirements while assisting investors in managing and leveraging this information. Thomson StreetEvents service offers institutional investors a one-stop solution for managing corporate disclosure information by aggregating conference calls, webcasts, transcripts, call summaries, and other financial information into a time-saving, efficiency tool.
Purchase Thomson StreetEvents' Transcripts (verbatim reports) and Briefs (call summaries) of earnings, guidance, M&A and other corporate calls directly through Alacra. Discounted prices apply to reports produced over two weeks ago.

About the Author


Cite this Report

  
MLA:
Thomson StreetEvents. "Arcadia Biosciences Inc Q4 2023 Earnings Call Transcript" Mar 28, 2024. Alacra Store. Nov 06, 2026. <http://www.alacrastore.com/thomson-streetevents-transcripts/Q4-2023-Arcadia-Biosciences-Inc-Earnings-Call-T15920947>
  
APA:
Thomson StreetEvents. (2024). Arcadia Biosciences Inc Q4 2023 Earnings Call Transcript Mar 28, 2024. New York, NY: Alacra Store. Retrieved Nov 06, 2026 from <http://www.alacrastore.com/thomson-streetevents-transcripts/Q4-2023-Arcadia-Biosciences-Inc-Earnings-Call-T15920947>
  
US$ 54.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Credit Research from one place.